Intractable anemia due to extensive refractory angiodysplasia of the small intestine stabilized by an anti-angiogenic agent.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Presse medicale

• Publication date

  2017-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.lpm.2016.11.023PMID 28062159
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Long-Term Therapy With Bevacizumab in a Patient With Glanzmann’s Thrombasthenia and Recurrent Digestive Bleeding due to Gastrointestinal Angiodysplastic Lesions

  2015cited by this paper
• Dose – response relationship of bevacizumab in hereditary hemorrhagic telangiectasia

  2015cited by this paper
• Review article: gastrointestinal angiodysplasia – pathogenesis, diagnosis and management

  2014cited by this paper
• Role of vascular endothelial growth factor in angiodysplasia: An interventional study with thalidomide

  2012cited by this paper
• Bevacizumab in patients with hereditary hemorrhagic telangiectasia and severe hepatic vascular malformations and high cardiac output.

  2012cited by this paper

• No citing papers are available for this paper.